The HLA Pre-Transplant Workup Panel 2 Test is a comprehensive diagnostic procedure designed to evaluate the compatibility between organ donors and recipients before transplantation. This test is crucial in minimizing the risk of organ rejection and ensuring the success of the transplant. It involves a detailed analysis of the human leukocyte antigen (HLA) system, which plays a significant role in the immune response and is a key factor in determining the compatibility between donor and recipient tissues.
Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, this test offers precise and reliable results. The cost of the HLA Pre-Transplant Workup Panel 2 Test is 4050 AED. The test includes a series of assessments to identify the specific HLA markers of both the donor and recipient. This information helps in matching organs more accurately and in planning for any necessary immunosuppressive treatments post-transplantation.
Choosing DNA Labs UAE for this critical test ensures access to state-of-the-art technology and expertise in genetic analysis, providing both patients and healthcare providers with valuable insights to make informed decisions regarding organ transplantation.
The ADAMTS13 Activity Test is a specialized blood test designed to measure the activity level of the ADAMTS13 enzyme in the blood. This enzyme plays a crucial role in the regulation of blood clotting by breaking down large protein complexes called von Willebrand factor (vWF) multimers. When ADAMTS13 activity is reduced, it can lead to the accumulation of these large vWF multimers, increasing the risk of inappropriate blood clot formation, a condition known as thrombotic thrombocytopenic purpura (TTP). TTP is a rare but life-threatening disorder that requires prompt diagnosis and treatment.
The test is particularly important for diagnosing TTP and distinguishing it from other thrombotic microangiopathies (TMAs), which have similar clinical presentations but different treatment approaches. By measuring the activity of the ADAMTS13 enzyme, healthcare providers can make informed decisions regarding the most appropriate treatment strategies for affected patients.
In the United Arab Emirates, the ADAMTS13 Activity Test is available at DNA Labs UAE, a leading diagnostic and research facility known for its comprehensive range of tests and state-of-the-art technology. The cost of the ADAMTS13 Activity Test at DNA Labs UAE is 4800 AED. This investment in health can be pivotal for individuals experiencing symptoms suggestive of TTP or for those with a known risk of the disorder, providing them with a crucial diagnostic tool to guide their treatment and management plan.
The GI Gastrointestinal Panel Stool Test is a comprehensive diagnostic tool used to evaluate the health and function of the gastrointestinal tract. This test is conducted at DNA Labs UAE, a leading provider of medical testing services. Priced at 4680 AED, the GI Gastrointestinal Panel is designed to detect a wide range of pathogens, including bacteria, viruses, parasites, and fungi, that can cause gastrointestinal infections and disorders. Additionally, it assesses digestive functions, inflammation markers, and the presence of blood, providing a holistic overview of the GI tract's condition. The test is performed using a stool sample, making it a non-invasive method to diagnose and monitor various GI conditions effectively. DNA Labs UAE ensures accurate and reliable results, aiding healthcare professionals in devising appropriate treatment plans for their patients.
The Meningoencephalitis Panel CSF Test is a comprehensive diagnostic examination designed to detect the presence of pathogens that can cause meningitis and encephalitis. Conducted on a sample of cerebrospinal fluid (CSF), this panel test is crucial for identifying the specific microorganisms, including bacteria, viruses, fungi, and parasites, responsible for the inflammation of the brain and its surrounding membranes. Early detection through this panel is vital for the prompt treatment of these potentially life-threatening conditions.
Administered at DNA Labs UAE, a leading facility in medical diagnostics, the test ensures high accuracy and reliability. The cost of the Meningoencephalitis Panel CSF Test is 4680 AED. Given the complexity of the diseases it helps to diagnose, this test is an essential tool in the arsenal of healthcare providers, offering critical insights that guide treatment strategies and improve patient outcomes.
The Pneumonia Plus Panel Test is a comprehensive diagnostic examination available at DNA Labs UAE, designed to accurately identify the presence of pathogens that cause pneumonia. This advanced test panel is capable of detecting a wide range of bacteria, viruses, and fungi responsible for pneumonia, providing clinicians with critical information for the diagnosis, treatment, and management of patients. With a test cost of 4680 AED, the Pneumonia Plus Panel Test employs state-of-the-art molecular techniques to ensure high sensitivity and specificity, making it a valuable tool in the timely identification of the causative agents of pneumonia. This facilitates targeted treatment approaches, potentially leading to improved patient outcomes. Conducted in the sophisticated facilities of DNA Labs UAE, this test represents a significant advancement in the field of infectious disease diagnostics, offering a comprehensive solution for healthcare providers dealing with respiratory infections.
The "Cancer Targeted Gene Panel CNS Tumor Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to analyze specific genes associated with central nervous system (CNS) tumors. This advanced genetic test aims to identify mutations within a select panel of genes that are known to play a significant role in the development, progression, and response to treatment of CNS tumors. By pinpointing these genetic alterations, healthcare providers can tailor more effective and personalized treatment plans for patients, potentially improving outcomes. The test is priced at 4680 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high-quality, reliable results for patients and their families. This test represents a crucial step forward in the field of precision medicine, offering hope for better management of CNS tumors through targeted therapeutic strategies.
The Cancer Targeted Gene Panel Gastrointestinal Stromal Tumor (GIST) Test, offered by DNA Labs UAE, is a specialized diagnostic tool designed to identify specific genetic mutations associated with Gastrointestinal Stromal Tumors. This test is crucial for the personalized treatment and management of GIST, a type of tumor that originates in the digestive tract's connective tissue. By analyzing a panel of genes known to be involved in GIST, this test helps in determining the most effective treatment options for patients, including targeted therapies that can significantly improve outcomes. The test cost is 4680 AED, making it a valuable investment for those seeking tailored treatment strategies based on their genetic profile.
The "Cancer Targeted Gene Panel Lung Test" is a sophisticated diagnostic tool designed to provide comprehensive genetic insights into lung cancer. Conducted at DNA Labs UAE, this test specifically screens for a wide array of genetic mutations and alterations associated with lung cancer, enabling personalized treatment strategies. By analyzing a patient's DNA, the test identifies specific genetic markers that can influence the behavior of lung cancer, including how aggressive it might be or how it might respond to certain treatments.
The cost of the Cancer Targeted Gene Panel Lung Test is 4680 AED. This investment allows healthcare providers to tailor treatment plans more effectively, potentially improving patient outcomes by targeting therapy to the individual's genetic profile. This approach not only enhances the precision of lung cancer treatment but also may reduce the likelihood of adverse side effects by avoiding ineffective treatments. Conducted at the state-of-the-art facilities of DNA Labs UAE, this test represents a significant step forward in the personalized medicine approach to cancer care, offering hope for more effective management of lung cancer.
The HLA Single Antigen Bead (SAB) Assay for Class II IgG Antibodies, also known as the DSA-SAB Class II Test, is a highly specialized laboratory test performed to detect and identify specific antibodies directed against Human Leukocyte Antigen (HLA) Class II molecules. This test is crucial in the field of transplantation medicine, as the presence of these donor-specific antibodies (DSA) can significantly impact the success of organ transplants, particularly in kidney and bone marrow transplants. The assay utilizes microbeads coated with purified HLA Class II antigens, allowing for the precise identification of antibodies against these antigens in the patient's serum.
Conducted at DNA Labs UAE, a leading diagnostic and research facility, the test employs state-of-the-art technology to ensure accurate and reliable results. The cost of the test is 4680 AED, reflecting the complexity and the specialized nature of the assay. This test is instrumental for clinicians in making informed decisions regarding organ transplantation, including assessing the risk of rejection and guiding immunosuppressive therapy. Patients undergoing evaluation for transplantation or those who have received a transplant may be recommended to undergo this test as part of their treatment and monitoring plan.
The IgVH Hypermutation Analysis Confirmatory Test is a sophisticated diagnostic procedure designed to analyze the immunoglobulin heavy chain variable region (IgVH) for somatic hypermutation. This test is crucial in the clinical setting for patients with chronic lymphocytic leukemia (CLL) and other B-cell disorders, as the presence or absence of somatic hypermutations in the IgVH gene has significant prognostic implications. Patients with unmutated IgVH genes tend to have a more aggressive disease course and poorer prognosis, making this test essential for guiding treatment decisions and predicting patient outcomes.
Performed at DNA Labs UAE, a leading facility in genetic testing and analysis, this test utilizes cutting-edge technology to ensure accurate and reliable results. The cost of the IgVH Hypermutation Analysis Confirmatory Test is 4680 AED. This investment in diagnostic precision enables healthcare providers to tailor treatment strategies more effectively, offering a personalized approach to patient care in the context of B-cell malignancies.
